State Tipoffs Involving Delaware Newsletter for Sunday January 19, 2025 ( 10 items ) |
AG Nessel Reaches $19.85 Million Multistate Medicaid Fraud Settlement with Behavioral Health Facility
LANSING, Michigan, Jan. 14 -- Michigan Attorney General Dana Nessel issued the following news release:
Michigan Attorney General Dana Nessel announced today that the State of Michigan, alongside other states and the federal government, has entered into a settlement agreement with Acadia Healthcare Company (Acadia) concerning allegations that their inpatient behavioral health facilities submitted false claims to government healthcare programs, primarily Medicare and Medicaid. Under the civil set
more
AstraZeneca: Calquence Plus Chemoimmunotherapy Approved in the US for Patients With Previously Untreated Mantle Cell Lymphoma
WILMINGTON, Delaware, Jan. 18 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
First and only BTK inhibitor approved for the 1st-line treatment of MCL in the US
* * *
AstraZeneca's CALQUENCE (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult
more
AstraZeneca: Datopotamab Deruxtecan Granted Priority Review in the US for Patients With Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
WILMINGTON, Delaware, Jan. 14 (TNSjou) -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
Application based on TROPION-Lung05 trial and supported by data from TROPION-Lung01 and TROPION-PanTumor01 trials
Approval would mark the first for AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in lung cancer
* * *
AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority
more
AstraZeneca: Datroway Approved in the US for Patients With Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer
WILMINGTON, Delaware, Jan. 18 (TNSjou) -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
First approval in the US for AstraZeneca and Daiichi Sankyo's DATROWAY based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or death vs. chemotherapy
DATROWAY is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030
* * *
DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of
more
Del. A.G. Jennings Takes Action to Protect Dreamers' Affordable Care Act Access
DOVER, Delaware, Jan. 16 -- Delaware Attorney General Kathy Jennings issued the following news release on Jan. 15, 2025:
* * *
Delaware steps in to fill legal void in Court challenge to health care access
* * *
Attorney General Kathy Jennings today announced that Delaware, New Jersey, and 12 other states are joining together to defend health insurance access for Dreamers from court challenges.
The motion to intervene comes as the incoming Trump Administration is expected to halt federal eff
more
Del. A.G. Jennings' Applauds Two Major Gun Safety Wins
DOVER, Delaware, Jan. 15 -- Delaware Attorney General Kathy Jennings issued the following statement on Jan. 13, 2025:
* * *
Attorney General Jennings released the following statement on today's Supreme Court of the United States' decision to deny two writs of certiorari, refusing to entertain a challenge to Delaware's assault weapon and large capacity magazine ban and refusing a challenge to Maryland's gun licensing law:
"This is a huge win for gun safety in our state and in our country. With
more
Highmark Blue Cross Blue Shield Delaware and the Delaware Community Foundation Announce Enhancements to BluePrints for the Community Fund
PITTSBURGH, Pennsylvania, Jan. 17 -- Highmark Blue Cross Blue Shield Delaware, a subsidiary of Highmark, issued the following news release:
Wilmington, Del. (January 16, 2025) -- Highmark Blue Cross Blue Shield Delaware (Highmark Delaware) and the Delaware Community Foundation (DCF) today announced significant enhancements to the BluePrints for the Community grant program, designed to further its mission of ensuring equitable access to healthcare and improving the well-being of Delawareans.
Si
more
Ohio Wesleyan University: 2025 Melvin Van Peebles Symposium
DELAWARE, Ohio, Jan. 17 -- Ohio Wesleyan University issued the following news release:
* * *
Artists Alicia Brown, Lance Johnson to Join Actress Erika Alexander in March at Ohio Wesleyan Event
* * *
Visual artists Alicia Brown and Lance Johnson will highlight Ohio Wesleyan University's 2025 Melvin Van Peebles Symposium, which also will feature award-winning actress and activist Erika Alexander as its keynote speaker.
Born in Jamaica, Alicia Brown uses portraiture to investigate colonial his
more
Singers unite Jan. 24 for 'Choral Tribute to Dr. Martin Luther King Jr.'
UNIVERSITY PARK, Pennsylvania, Jan. 13 -- Pennsylvania State University issued the following news:
Pennsylvania artists will perform alongside Delaware state professional vocal ensemble Elevation to sing hymns and spirituals that celebrate the legacy of the civil-rights champion.
"A Choral Tribute to Dr. Martin Luther King Jr." will be held at 7 p.m. Friday, Jan. 24, in Eisenhower Auditorium on Penn State's University Park campus.
The event is general admission. Call 814-863-0255 or visit "
more
Troutman Pepper Locke Advises EMG and Medallion in Sale of Crude Oil Business in Delaware Basin to Plains Oryx Permian Basin
ATLANTA, Georgia, Jan. 14 -- Troutman Pepper, a law firm, issued the following news:
HOUSTON -- Troutman Pepper Locke represented The Energy & Minerals Group (EMG) and EMG Medallion 2 Holdings, LLC (Medallion), an EMG portfolio company that owns over 140 miles of crude oil pipelines and approximately 106,000 barrels of crude oil storage capacity in the core of the southern Delaware Basin, in its sale of 100% of the membership interests of Medallion to a wholly owned subsidiary of Plains Oryx Pe
more
|
Sign up to Receive this newsletter every day via email.